AbbVie Inc. (ABBV) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbvie Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:01.990 Good morning, and thank you for standing by. 00:00:01.990 -- 00:00:06.393 Welcome to the FV Third Quarter 2023 Earnings Conference Call. 00:00:06.393 -- 00:00:09.014 All participants will 00:00:09.456 -- 00:00:13.458 be in a listen-only mode until the question and answer portion of this call. 00:00:13.458 -- 00:00:16.561 You may ask a question by pressing star 1 on your phone. 00:00:16.561 -- 00:00:20.743 I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations. 00:00:20.743 -- 00:00:22.685 Thank you. You may begin. 00:00:22.685 -- 00:00:27.245 Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, 00:00:27.245 -- 00:00:31.848 Chairman of the Board and Chief Executive Officer, Rob Michael, President and Chief Operating 00:00:31.848 -- 00:00:37.112 Officer, Jeff Stewart, Executive Vice President, Chief Commercial Officer, Scott Rentz, 00:00:37.112 -- 00:00:41.855 Executive Vice President, Chief Financial Officer, Carrie Strom, Senior Vice President, 00:00:41.855 -- 00:00:46.399 Abbey and President, Global Allergan Aesthetics, and Tom Hudson, Senior Vice President, 00:00:46.399 -- 00:00:50.781 R&D and Chief Scientific Officer. Joining us for the Q&A portion of the call is Rupal 00:00:50.781 -- 00:00:54.703 Thakkar, Senior Vice President, Development and Regulatory Affairs, and Chief Medical 00:00:54.703 -- 00:00:59.205 Officer. Before we get started, I'll note that some statements we make today may be considered 00:00:59.205 -- 00:01:02.227 forward-looking statements based on our current expectations. 00:01:02.227 -- 00:01:05.949 Add the cautions that these forward-looking statements are subject to risks and uncertainties 00:01:05.949 -- 00:01:09.911 that may cause actu...